Hypersensitivity, Delayed
"Hypersensitivity, Delayed" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An increased reactivity to specific antigens mediated not by antibodies but by cells.
| Descriptor ID |
D006968
|
| MeSH Number(s) |
C20.543.418
|
| Concept/Terms |
Hypersensitivity, Delayed- Hypersensitivity, Delayed
- Hypersensitivity, Type IV
- Hypersensitivities, Type IV
- Type IV Hypersensitivities
- Delayed Hypersensitivity
- Delayed Hypersensitivities
- Hypersensitivities, Delayed
- Type IV Hypersensitivity
- Hypersensitivity, Tuberculin-Type
- Hypersensitivities, Tuberculin-Type
- Hypersensitivity, Tuberculin Type
- Tuberculin-Type Hypersensitivities
- Tuberculin-Type Hypersensitivity
- Tuberculin Type Hypersensitivity
|
Below are MeSH descriptors whose meaning is more general than "Hypersensitivity, Delayed".
Below are MeSH descriptors whose meaning is more specific than "Hypersensitivity, Delayed".
This graph shows the total number of publications written about "Hypersensitivity, Delayed" by people in this website by year, and whether "Hypersensitivity, Delayed" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 3 | 3 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 3 | 0 | 3 |
| 2008 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2017 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypersensitivity, Delayed" by people in Profiles.
-
Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune response. Clin Immunol. 2018 07; 192:6-13.
-
Immunostimulatory activity of plumieride an iridoid in augmenting immune system by targeting Th-1 pathway in balb/c mice. Int Immunopharmacol. 2017 Jul; 48:203-210.
-
Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog. Clin Immunol. 2017 07; 180:45-57.
-
Mechanisms of Drug-Induced Interstitial Nephritis. Adv Chronic Kidney Dis. 2017 03; 24(2):64-71.
-
Serotonin signalling is crucial in the induction of PUVA-induced systemic suppression of delayed-type hypersensitivity but not local apoptosis or inflammation of the skin. Exp Dermatol. 2016 07; 25(7):537-43.
-
Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases. FASEB J. 2014 Sep; 28(9):3952-64.
-
Pulmonary contusion is associated with toll-like receptor 4 upregulation and decreased susceptibility to pseudomonas pneumonia in a mouse model. Shock. 2012 Jun; 37(6):629-33.
-
Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseases. Inflamm Allergy Drug Targets. 2011 Oct; 10(5):313-21.
-
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma. Neuro Oncol. 2011 Mar; 13(3):324-33.
-
The impact of HER2/neu expression level on response to the E75 vaccine: from U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02. Clin Cancer Res. 2009 Apr 15; 15(8):2895-904.